Cambridge-based Congenica is being acquired for an undisclosed sum by French company SeqOne but the new entity will retain a base at the Wellcome Sanger Institute from where it was spun out.

The first resource containing high-resolution DNA sequencing data for over 37,000 children and parents collected over multiple decades from across the UK is now available to researchers worldwide. The...

For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management. CIC Partner Michael Anstey, who special...

Sortera Bio Ltd has spun out of the Medical Research Council Laboratory of Molecular Biology (MRC LMB) to pioneer a Deep Screening platform set to redefine early biologics discovery and engineering. I...

ExpressionEdits in Cambridge has clinched unspecified riches from global pharmaceutical company Boehringer Ingelheim through a collaboration and licensing agreement.

Cambridge Consultants, which is a DeepTech powerhouse subsidiary of French company Capgemini SE, is the brains behind a cutting edge advancement in generative AI.

US MedTech company ClariMed Inc. has unveiled a new study facility in Cambridge to advance human factors research capabilities.

A transatlantic Cambridge2Cambridge alliance between Qureight in the UK and Avalyn Pharma Inc in Massachusetts – is seeking to improve treatment of pulmonary fibrosis (PPF) for which there is currentl...

Since the heady highs of investment during the Covid years, it has been extremely challenging in terms of the funding environment for the region’s life science companies, impacting all stakeholders – ...

Cranfield University scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even bef...

Cambridge biotech company Astex belatedly celebrated its 25th anniversary in style with UK Science Minister and new trade tsar Lord Vallance leading the salutes at the company’s Science Park HQ.

Fiona Li learned early how cancer could end a life and devastate others within a circle of family or friends. She and a friend were inseparable. They would walk to and from school hand in hand, smilin...

Cambridge UK superchip architect Arm saw its stock on the Nasdaq market in the US climb almost seven per cent and $11 to $173.26 after posting record Q3 revenues. Its market cap hit $182.10 billion.

Paragraf, which is pioneering the mass production of graphene-based electronics with standard semiconductor processes, has been awarded a grant of c£420k from Innovate UK to produce a proof-of-concept...

Some market watchers had a quiet chuckle when Cambridge-based pharmaceutical giant AstraZeneca said it was targeting $80 billion total revenue by the end of the decade. They’re not laughing now!